Litcius/Paper detail

64Cu-labeled daratumumab F(ab′)2 fragment enables early visualization of CD38-positive lymphoma

Lei Kang, Cuicui Li, Qi Yang, Logan Sutherlin, Lin Wang, Zhao Chen, K. Becker, Nan Huo, Yongkang Qiu, Jonathan W. Engle, Rongfu Wang, Chengzhi He, Dawei Jiang, Xiaojie Xu, Weibo Cai

2021European Journal of Nuclear Medicine and Molecular Imaging27 citationsDOIOpen Access PDF

Topics & Concepts

DaratumumabFlow cytometryLymphomaMonoclonal antibodyChemistryCD38Molecular biologyAntibodyCancer researchNuclear medicineMedicinePathologyBiologyImmunologyCD34Stem cellGeneticsMonoclonal and Polyclonal Antibodies ResearchLymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia Research
64Cu-labeled daratumumab F(ab′)2 fragment enables early visualization of CD38-positive lymphoma | Litcius